메뉴 건너뛰기




Volumn 7, Issue 1, 2013, Pages 25-30

Fibroblast growth factor 21: A novel metabolic regulator from pharmacology to physiology

Author keywords

clinical relevance; FGF21; metabolism; pharmacology; physiology

Indexed keywords


EID: 84874800718     PISSN: 16737342     EISSN: 16737458     Source Type: Journal    
DOI: 10.1007/s11684-013-0244-8     Document Type: Review
Times cited : (63)

References (55)
  • 1
    • 0034697846 scopus 로고    scopus 로고
    • Identification of a novel FGF, FGF-21, preferentially expressed in the liver
    • Nishimura T, Nakatake Y, Konishi M, Itoh N. Identification of a novel FGF, FGF-21, preferentially expressed in the liver. Biochim Biophys Acta 2000; 1492(1): 203-206.
    • (2000) Biochim Biophys Acta , vol.1492 , Issue.1 , pp. 203-206
    • Nishimura, T.1    Nakatake, Y.2    Konishi, M.3    Itoh, N.4
  • 3
    • 4744372082 scopus 로고    scopus 로고
    • Evolution of the Fgf and Fgfr gene families
    • Itoh N, Ornitz DM. Evolution of the Fgf and Fgfr gene families. Trends Genet 2004; 20(11): 563-569.
    • (2004) Trends Genet , vol.20 , Issue.11 , pp. 563-569
    • Itoh, N.1    Ornitz, D.M.2
  • 6
    • 0034703619 scopus 로고    scopus 로고
    • Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain
    • Yamashita T, Yoshioka M, Itoh N. Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain. Biochem Biophys Res Commun 2000; 277(2): 494-498.
    • (2000) Biochem Biophys Res Commun , vol.277 , Issue.2 , pp. 494-498
    • Yamashita, T.1    Yoshioka, M.2    Itoh, N.3
  • 7
    • 0033579972 scopus 로고    scopus 로고
    • Structure and expression of a novel human FGF, FGF-19, expressed in the fetal brain
    • Nishimura T, Utsunomiya Y, Hoshikawa M, Ohuchi H, Itoh N. Structure and expression of a novel human FGF, FGF-19, expressed in the fetal brain. Biochim Biophys Acta 1999; 1444(1): 148-151.
    • (1999) Biochim Biophys Acta , vol.1444 , Issue.1 , pp. 148-151
    • Nishimura, T.1    Utsunomiya, Y.2    Hoshikawa, M.3    Ohuchi, H.4    Itoh, N.5
  • 9
    • 33751115468 scopus 로고    scopus 로고
    • Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man
    • Lundåsen T, Gälman C, Angelin B, Rudling M. Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man. J Intern Med 2006; 260(6): 530-536.
    • (2006) J Intern Med , vol.260 , Issue.6 , pp. 530-536
    • Lundåsen, T.1    Gälman, C.2    Angelin, B.3    Rudling, M.4
  • 10
    • 34047260591 scopus 로고    scopus 로고
    • FGF23 is a hormone-regulating phosphate metabolism-unique biological characteristics of FGF23
    • Fukumoto S, Yamashita T. FGF23 is a hormone-regulating phosphate metabolism-unique biological characteristics of FGF23. Bone 2007; 40(5): 1190-1195.
    • (2007) Bone , vol.40 , Issue.5 , pp. 1190-1195
    • Fukumoto, S.1    Yamashita, T.2
  • 12
    • 38549092079 scopus 로고    scopus 로고
    • Fibroblast growth factor-21 as a therapeutic agent for metabolic diseases
    • Kharitonenkov A, Shanafelt AB. Fibroblast growth factor-21 as a therapeutic agent for metabolic diseases. BioDrugs 2008; 22(1): 37-44.
    • (2008) BioDrugs , vol.22 , Issue.1 , pp. 37-44
    • Kharitonenkov, A.1    Shanafelt, A.B.2
  • 22
    • 33750587755 scopus 로고    scopus 로고
    • Fibroblast growth factor-21 improves pancreatic beta-cell function and survival by activation of extracellular signal-regulated kinase 1/2 and Akt signaling pathways
    • Wente W, Efanov AM, Brenner M, Kharitonenkov A, Köster A, Sandusky GE, Sewing S, Treinies I, Zitzer H, Gromada J. Fibroblast growth factor-21 improves pancreatic beta-cell function and survival by activation of extracellular signal-regulated kinase 1/2 and Akt signaling pathways. Diabetes 2006; 55(9): 2470-2478.
    • (2006) Diabetes , vol.55 , Issue.9 , pp. 2470-2478
    • Wente, W.1    Efanov, A.M.2    Brenner, M.3    Kharitonenkov, A.4    Köster, A.5    Sandusky, G.E.6    Sewing, S.7    Treinies, I.8    Zitzer, H.9    Gromada, J.10
  • 25
    • 34249711964 scopus 로고    scopus 로고
    • Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states
    • Badman MK, Pissios P, Kennedy AR, Koukos G, Flier JS, Maratos-Flier E. Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states. Cell Metab 2007; 5(6): 426-437.
    • (2007) Cell Metab , vol.5 , Issue.6 , pp. 426-437
    • Badman, M.K.1    Pissios, P.2    Kennedy, A.R.3    Koukos, G.4    Flier, J.S.5    Maratos-Flier, E.6
  • 28
    • 77249099832 scopus 로고    scopus 로고
    • Hepatic FGF21 expression is induced at birth via PPARalpha in response to milk intake and contributes to thermogenic activation of neonatal brown fat
    • Hondares E, Rosell M, Gonzalez FJ, Giralt M, Iglesias R, Villarroya F. Hepatic FGF21 expression is induced at birth via PPARalpha in response to milk intake and contributes to thermogenic activation of neonatal brown fat. Cell Metab 2010; 11(3): 206-212.
    • (2010) Cell Metab , vol.11 , Issue.3 , pp. 206-212
    • Hondares, E.1    Rosell, M.2    Gonzalez, F.J.3    Giralt, M.4    Iglesias, R.5    Villarroya, F.6
  • 29
    • 34249677947 scopus 로고    scopus 로고
    • FGF21: a missing link in the biology of fasting
    • Reitman ML. FGF21: a missing link in the biology of fasting. Cell Metab 2007; 5(6): 405-407.
    • (2007) Cell Metab , vol.5 , Issue.6 , pp. 405-407
    • Reitman, M.L.1
  • 30
    • 84863012459 scopus 로고    scopus 로고
    • Fibroblast growth factor-21 regulates PPARγ activity and the antidiabetic actions of thiazolidinediones
    • Dutchak PA, Katafuchi T, Bookout AL, Choi JH, Yu RT, Mangelsdorf DJ, Kliewer SA. Fibroblast growth factor-21 regulates PPARγ activity and the antidiabetic actions of thiazolidinediones. Cell 2012; 148(3): 556-567.
    • (2012) Cell , vol.148 , Issue.3 , pp. 556-567
    • Dutchak, P.A.1    Katafuchi, T.2    Bookout, A.L.3    Choi, J.H.4    Yu, R.T.5    Mangelsdorf, D.J.6    Kliewer, S.A.7
  • 31
    • 0028127946 scopus 로고
    • Nutritional regulation of the insulin-like growth factors
    • Thissen JP, Ketelslegers JM, Underwood LE. Nutritional regulation of the insulin-like growth factors. Endocr Rev 1994; 15(1): 80-101.
    • (1994) Endocr Rev , vol.15 , Issue.1 , pp. 80-101
    • Thissen, J.P.1    Ketelslegers, J.M.2    Underwood, L.E.3
  • 33
    • 80053409251 scopus 로고    scopus 로고
    • Growth hormone induces hepatic production of fibroblast growth factor 21 through a mechanism dependent on lipolysis in adipocytes
    • Chen W, Hoo RL, Konishi M, Itoh N, Lee PC, Ye HY, Lam KS, Xu A. Growth hormone induces hepatic production of fibroblast growth factor 21 through a mechanism dependent on lipolysis in adipocytes. J Biol Chem 2011; 286(40): 34559-34566.
    • (2011) J Biol Chem , vol.286 , Issue.40 , pp. 34559-34566
    • Chen, W.1    Hoo, R.L.2    Konishi, M.3    Itoh, N.4    Lee, P.C.5    Ye, H.Y.6    Lam, K.S.7    Xu, A.8
  • 36
    • 0037251008 scopus 로고    scopus 로고
    • Cold-induced recruitment of brown adipose tissue thermogenesis
    • Klingenspor M. Cold-induced recruitment of brown adipose tissue thermogenesis. Exp Physiol 2003; 88(1): 141-148.
    • (2003) Exp Physiol , vol.88 , Issue.1 , pp. 141-148
    • Klingenspor, M.1
  • 37
    • 0029872696 scopus 로고    scopus 로고
    • Thermoregulation with age: restoration of beta(3)-adrenergic responsiveness in brown adipose tissue by cold exposure
    • Scarpace PJ, Tse C, Matheny M. Thermoregulation with age: restoration of beta(3)-adrenergic responsiveness in brown adipose tissue by cold exposure. Proc Soc Exp Biol Med 1996; 211(4): 374-380.
    • (1996) Proc Soc Exp Biol Med , vol.211 , Issue.4 , pp. 374-380
    • Scarpace, P.J.1    Tse, C.2    Matheny, M.3
  • 38
    • 0027030305 scopus 로고
    • Importance of sympathetic nerves for the stimulatory effect of cold exposure on glucose utilization in brown adipose tissue
    • Takahashi A, Shimazu T, Maruyama Y. Importance of sympathetic nerves for the stimulatory effect of cold exposure on glucose utilization in brown adipose tissue. Jpn J Physiol 1992; 42(4): 653-664.
    • (1992) Jpn J Physiol , vol.42 , Issue.4 , pp. 653-664
    • Takahashi, A.1    Shimazu, T.2    Maruyama, Y.3
  • 41
    • 69949107891 scopus 로고    scopus 로고
    • Circulating fibroblast growth factor 21 is induced by peroxisome proliferator-activated receptor agonists but not ketosis in man
    • Christodoulides C, Dyson P, Sprecher D, Tsintzas K, Karpe F. Circulating fibroblast growth factor 21 is induced by peroxisome proliferator-activated receptor agonists but not ketosis in man. J Clin Endocrinol Metab 2009; 94(9): 3594-3601.
    • (2009) J Clin Endocrinol Metab , vol.94 , Issue.9 , pp. 3594-3601
    • Christodoulides, C.1    Dyson, P.2    Sprecher, D.3    Tsintzas, K.4    Karpe, F.5
  • 44
    • 75149195216 scopus 로고    scopus 로고
    • Fibroblast growth factor-21 may mediate growth hormone resistance in anorexia nervosa
    • Fazeli PK, Misra M, Goldstein M, Miller KK, Klibanski A. Fibroblast growth factor-21 may mediate growth hormone resistance in anorexia nervosa. J Clin Endocrinol Metab 2010; 95(1): 369-374.
    • (2010) J Clin Endocrinol Metab , vol.95 , Issue.1 , pp. 369-374
    • Fazeli, P.K.1    Misra, M.2    Goldstein, M.3    Miller, K.K.4    Klibanski, A.5
  • 45
  • 46
    • 68149091653 scopus 로고    scopus 로고
    • Circulating fibroblast growth factor-21 is elevated in impaired glucose tolerance and type 2 diabetes and correlates with muscle and hepatic insulin resistance
    • Chavez AO, Molina-Carrion M, Abdul-Ghani MA, Folli F, Defronzo RA, Tripathy D. Circulating fibroblast growth factor-21 is elevated in impaired glucose tolerance and type 2 diabetes and correlates with muscle and hepatic insulin resistance. Diabetes Care 2009; 32(8): 1542-1546.
    • (2009) Diabetes Care , vol.32 , Issue.8 , pp. 1542-1546
    • Chavez, A.O.1    Molina-Carrion, M.2    Abdul-Ghani, M.A.3    Folli, F.4    Defronzo, R.A.5    Tripathy, D.6
  • 49
    • 66749106885 scopus 로고    scopus 로고
    • Serum fibroblast growth factor 21 is associated with adverse lipid profiles and gamma-glutamyltransferase but not insulin sensitivity in Chinese subjects
    • Li H, Bao Y, Xu A, Pan X, Lu J, Wu H, Lu H, Xiang K, Jia W. Serum fibroblast growth factor 21 is associated with adverse lipid profiles and gamma-glutamyltransferase but not insulin sensitivity in Chinese subjects. J Clin Endocrinol Metab 2009; 94(6): 2151-2156.
    • (2009) J Clin Endocrinol Metab , vol.94 , Issue.6 , pp. 2151-2156
    • Li, H.1    Bao, Y.2    Xu, A.3    Pan, X.4    Lu, J.5    Wu, H.6    Lu, H.7    Xiang, K.8    Jia, W.9
  • 50
    • 77957359658 scopus 로고    scopus 로고
    • Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride
    • Li H, Fang Q, Gao F, Fan J, Zhou J, Wang X, Zhang H, Pan X, Bao Y, Xiang K, Xu A, Jia W. Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride. J Hepatol 2010; 53(5): 934-940.
    • (2010) J Hepatol , vol.53 , Issue.5 , pp. 934-940
    • Li, H.1    Fang, Q.2    Gao, F.3    Fan, J.4    Zhou, J.5    Wang, X.6    Zhang, H.7    Pan, X.8    Bao, Y.9    Xiang, K.10    Xu, A.11    Jia, W.12
  • 51
    • 77950546742 scopus 로고    scopus 로고
    • Evaluation of concentrations of FGF-21 - a new adipocytokine in type 2 diabetes
    • Matuszek B, Lenart-Lipińska M, Duma D, Solski J, Nowakowski A. Evaluation of concentrations of FGF-21 - a new adipocytokine in type 2 diabetes. Endokrynol Pol 2010; 61(1): 50-54.
    • (2010) Endokrynol Pol , vol.61 , Issue.1 , pp. 50-54
    • Matuszek, B.1    Lenart-Lipińska, M.2    Duma, D.3    Solski, J.4    Nowakowski, A.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.